More on Culture-Based Psychiatry >>
September 28th, 2026Fewer Than 1 in 5 Young Patients With First-Episode Psychosis Adhere to AntipsychoticsStudy finds most teens with first-episode psychosis stop antipsychotics within a year, boosting ER use; outpatient care and injectables may help.Read more
September 28th, 2026Dissecting Algorithms of the Mind: Toward Precision Psychiatry in SchizophreniaExperts highlight biomarker-driven schizophrenia care—computational subtypes, muscarinic drugs, sharper negative-symptom scoring, and KCC2 targets—reducing trial-and-error prescribing.Read more
September 28th, 2026Evidence-Based Pharmacologic Approaches to Reducing Suicide RiskLearn how clozapine, lithium, ketamine, and antidepressants fit into suicide prevention, from rapid crisis relief to long-term risk reduction.Read more
September 25th, 2026Exploring a Misuse of Neuroscience: How Biology Has Been Used to Remove Responsibility in YouthCourts cite teen brain science to soften sentences; experts warn generalized neuroscience overreaches and adult responsibility stabilizes by 18 to 20.Read more
September 25th, 2026Endocrine Biomarkers of Suicidality in SchizophreniaCan hormones flag suicide risk in schizophrenia? Review links cortisol, thyroid and testosterone shifts—and clozapine/lithium pathways—to risk.Read more
September 24th, 2026Treating PTSD Among Veterans at Risk for SuicideHow VA clinicians treat veterans’ PTSD while managing suicide risk, using shared decisions, safety planning, and phase-based trauma therapies.Read more
September 24th, 2026Positive Phase 2 Topline Results: Remlifanserin for the Treatment of Alzheimer Disease PsychosisRADIANT phase 2 shows once-daily remlifanserin eases Alzheimer’s psychosis symptoms with placebo-like safety, advancing pivotal trials.Read more
September 23rd, 2026Using Psychotherapy for the Prevention of Relapse in SchizophreniaDiscover how integrated psychotherapy—CBTp, family support, and relapse plans—boosts schizophrenia recovery alongside antipsychotics.Read more